| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 05/06/2010 | 8:15AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/06/2010 | 8:15AM | Business Wire | BYDUREON™ FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/06/2010 | 8:00AM | PR Newswire (US) | BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/03/2010 | 6:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 6:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2010 | 4:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/29/2010 | 3:38PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/29/2010 | 3:38PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/27/2010 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/27/2010 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/27/2010 | 5:49AM | Dow Jones News | INTERVIEW: U.S. Victoza Roll-Out Key For Novo Nordisk - CFO | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2010 | 5:15PM | Business Wire | Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON™ | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2010 | 5:00PM | PR Newswire (US) | Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2010 | 11:21AM | Dow Jones News | UPDATE: Amylin 1Q Loss Narrows;To File FDA Response This Week | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2010 | 7:54AM | Dow Jones News | Amylin 1Q Loss Narrows On Lower Costs; Revenue, Margin Fall | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2010 | 7:21AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2010 | 7:00AM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/13/2010 | 9:07AM | Dow Jones News | Alkermes Submits FDA Application To Expand Vivitrol Approval | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/12/2010 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast First Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/07/2010 | 2:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |